80 related articles for article (PubMed ID: 21057934)
21. 32P-postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo(a)pyrene.
Lu LJ; Disher RM; Reddy MV; Randerath K
Cancer Res; 1986 Jun; 46(6):3046-54. PubMed ID: 3698023
[TBL] [Abstract][Full Text] [Related]
22. Benzo(a)pyrene-DNA adduct formation and removal in mouse epidermis in vivo and in vitro: relationship of DNA binding to initiation of skin carcinogenesis.
Nakayama J; Yuspa SH; Poirier MC
Cancer Res; 1984 Sep; 44(9):4087-95. PubMed ID: 6331664
[TBL] [Abstract][Full Text] [Related]
23. In vivo DNA adduct formation by benzo(a)pyrene in mouse and rat epidermal and dermal fibroblasts after topical application of an initiating dose of benzo(a)pyrene.
Alexandrov K; Rojas-Moreno M
Arch Geschwulstforsch; 1990; 60(5):329-40. PubMed ID: 2241509
[TBL] [Abstract][Full Text] [Related]
24. Divergent synergic effects in carcinogenesis initiation by simultaneous exposure to two genotoxic carcinogens.
Verdina A; Zito R; Federico A; Falasca G; Galati R
In Vivo; 2000; 14(6):753-6. PubMed ID: 11204494
[TBL] [Abstract][Full Text] [Related]
25. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity.
Alexandrov K; Rojas M; Geneste O; Castegnaro M; Camus AM; Petruzzelli S; Giuntini C; Bartsch H
Cancer Res; 1992 Nov; 52(22):6248-53. PubMed ID: 1423269
[TBL] [Abstract][Full Text] [Related]
26. Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination.
Shields PG; Kato S; Bowman ED; Petruzzelli S; Cooper DP; Povey AC; Weston A
IARC Sci Publ; 1993; (124):243-54. PubMed ID: 8225491
[TBL] [Abstract][Full Text] [Related]
27. Serum antibodies to benzo(a)pyrene diol epoxide-DNA adducts in the general population: effects of air pollution, tobacco smoking, and family history of lung diseases.
Petruzzelli S; Celi A; Pulerà N; Baliva F; Viegi G; Carrozzi L; Ciacchini G; Bottai M; Di Pede F; Paoletti P; Giuntini C
Cancer Res; 1998 Sep; 58(18):4122-6. PubMed ID: 9751623
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical demonstration of carcinogen-DNA adducts in tissues of rats given 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP): detection in paraffin-embedded sections and tissue distribution.
Takahashi S; Tamano S; Hirose M; Kimoto N; Ikeda Y; Sakakibara M; Tada M; Kadlubar FF; Ito N; Shirai T
Cancer Res; 1998 Oct; 58(19):4307-13. PubMed ID: 9766658
[TBL] [Abstract][Full Text] [Related]
29. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
Randerath K; Liehr JG; Gladek A; Randerath E
IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
[TBL] [Abstract][Full Text] [Related]
30. Benzo[A]pyrene-induced oral carcinogenesis and chemoprevention: studies in bioengineered human tissue.
Walle T; Walle UK; Sedmera D; Klausner M
Drug Metab Dispos; 2006 Mar; 34(3):346-50. PubMed ID: 16381670
[TBL] [Abstract][Full Text] [Related]
31. In situ detection of acetylaminofluorene-DNA adducts in human cells using monoclonal antibodies.
Iwamoto TA; Kobayashi N; Imoto K; Yamamoto A; Nakamura Y; Yamauchi Y; Okumura H; Tanaka A; Hanaoka F; Shibutani S; Miyagawa S; Mori T
DNA Repair (Amst); 2004 Nov; 3(11):1475-82. PubMed ID: 15380103
[TBL] [Abstract][Full Text] [Related]
32. Application of an immunoperoxidase staining method for detection of 7,8-dihydro-8-oxodeoxyguanosine as a biomarker of chemical-induced oxidative stress in marine organisms.
Machella N; Regoli F; Cambria A; Santella RM
Aquat Toxicol; 2004 Mar; 67(1):23-32. PubMed ID: 15019248
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of novel stable deoxyguanosine and deoxyadenosine adducts of benzo[a]pyrene-7,8-quinone from reactions at physiological pH.
Balu N; Padgett WT; Lambert GR; Swank AE; Richard AM; Nesnow S
Chem Res Toxicol; 2004 Jun; 17(6):827-38. PubMed ID: 15206904
[TBL] [Abstract][Full Text] [Related]
34. Novel biosensor chip for simultaneous detection of DNA-carcinogen adducts with low-temperature fluorescence.
Grubor NM; Shinar R; Jankowiak R; Porter MD; Small GJ
Biosens Bioelectron; 2004 Jan; 19(6):547-56. PubMed ID: 14683638
[TBL] [Abstract][Full Text] [Related]
35. The association between benzo[a]pyrene-DNA adducts and body mass index, calorie intake and physical activity.
Rundle A; Madsen A; Orjuela M; Mooney L; Tang D; Kim M; Perera F
Biomarkers; 2007; 12(2):123-32. PubMed ID: 17536763
[TBL] [Abstract][Full Text] [Related]
36. The use of carcinogen-DNA adduct antisera for quantitation and localization of genomic damage in animal models and the human population.
Poirier MC
Environ Mutagen; 1984; 6(6):879-87. PubMed ID: 6389112
[TBL] [Abstract][Full Text] [Related]
37. Quantitation of carcinogen-DNA adducts with monoclonal antibodies.
Santella RM; Gasparo F; Hsieh LL
Prog Exp Tumor Res; 1987; 31():63-75. PubMed ID: 3562860
[No Abstract] [Full Text] [Related]
38. Use of monoclonal and polyclonal antibodies against DNA adducts for the detection of DNA lesions in isolated DNA and in single cells.
Baan RA; Zaalberg OB; Fichtinger-Schepman AM; Muysken-Schoen MA; Lansbergen MJ; Lohman PH
Environ Health Perspect; 1985 Oct; 62():81-8. PubMed ID: 3910422
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibody--gold biosensor chips for detection of depurinating carcinogen--DNA adducts by fluorescence line-narrowing spectroscopy.
Duhachek SD; Kenseth JR; Casale GP; Small GJ; Porter MD; Jankowiak R
Anal Chem; 2000 Aug; 72(16):3709-16. PubMed ID: 10959953
[TBL] [Abstract][Full Text] [Related]
40. DNA adducts, DNA repair genotype/phenotype and cancer risk.
Santella RM; Gammon M; Terry M; Senie R; Shen J; Kennedy D; Agrawal M; Faraglia B; Zhang F
Mutat Res; 2005 Dec; 592(1-2):29-35. PubMed ID: 16023682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
